MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.
Lung cancer remains a leading cause of cancer-related mortality, with metastatic progression remaining the single largest cause of lung cancer mortality. Hence, it is imperative to determine reliable biomarkers of lung cancer prognosis. MicroRNA-490-3p has been previously reported to be a positive prognostic biomarker for hepatocellular cancer. However, its role in human lung cancer has not yet been elucidated. Here, we report that hsa-miR-490-3p expression is significantly higher in human lung cancer tissue specimens and cell line. Gain- and loss-of-function studies of hsa-miR-490-3p showed that it regulates cell proliferation and is required for induction of in vitro migration and invasion-the latter being a hallmark of epithelial to mesenchymal transition. In situ analysis revealed that hsa-miR-490-3p targets poly r(C)-binding protein 1 (PCBP1), which has been previously shown to be a negative regulator of lung cancer metastasis. Reporter assays confirmed PCBP1 as a bona fide target of miR-490-3p, and metagenomic analysis revealed an inverse relation between expression of miR-490-3p and PCBP1 in metastatic lung cancer patients. In fact, PCBP1 expression, as detected by immunohistochemistry, was undetectable in advanced stages of lung cancer patients' brain and lymph node tissues. Xenograft tail vein colonization assays proved that high expression of miR-490-3p is a prerequisite for metastatic progression of lung cancer. Our results suggest that hsa-miR-490-3p might be a potential biomarker for lung cancer prognosis. In addition, we can also conclude that the lung cancer cells have evolved refractory mechanisms to downregulate the expression of the metastatic inhibitor, PCBP1.
Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, No.127, Dongming Road, Zhengzhou, Henan, 450003, China. jdlihn@126.com.
Jindong
J
Li
Department of Cell Biology and Medical Genetics, Basical Medical College, Zhengzhou, Henan, 450008, China.
Qingchuan
Q
Feng
Department of Thoracic Surgery, Anyang Cancer Hospital, Anyang, Henan, 455000, China.
Xudong
X
Wei
Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, No.127, Dongming Road, Zhengzhou, Henan, 450003, China.
Yongkui
Y
Yu
D000818:Animals; D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D015153:Blotting, Western; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000378:metabolism / Q000556:secondary*; D016022:Case-Control Studies; D002465:Cell Movement; D049109:Cell Proliferation; D004268:DNA-Binding Proteins; D005260:Female; D034441:Heterogeneous-Nuclear Ribonucleoproteins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007124:Immunoenzyme Techniques; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008819:Mice, Nude; D035683:MicroRNAs / Q000235:genetics*; D009367:Neoplasm Staging; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics; D016601:RNA-Binding Proteins; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured; D023041:Xenograft Model Antitumor Assays
D014408:Biomarkers, Tumor; D004268:DNA-Binding Proteins; D034441:Heterogeneous-Nuclear Ribonucleoproteins; C574862:MIRN490 microRNA, human; D035683:MicroRNAs; C094604:PCBP1 protein, human; D012333:RNA, Messenger; D016601:RNA-Binding Proteins
EMT; Lung cancer; Metastasis; PCBP1; Poly r(C)-binding protein 1; miR-490-3p
Mol Cell. 2011 Feb 18;41(4):419-31
21329880
Int J Gynecol Cancer. 2012 Sep;22(7):1125-9
22801034
Mol Biol Rep. 2014 Aug;41(8):5519-24
24889597
Adv Drug Deliv Rev. 2015 Jan;81:16-33
25453266
Gene Expr Patterns. 2014 Mar;14(2):78-87
24480778
PLoS One. 2013 Aug 07;8(8):e71724
23940783
PLoS One. 2012;7(4):e34150
22529906
Lung Cancer. 2001 Dec;34 Suppl 2:S145-50
11720756
Cell. 2011 Oct 14;147(2):275-92
22000009
J Thorac Dis. 2010 Sep;2(3):154-9
22263037
Biochim Biophys Acta. 2015 Jan;1855(1):24-42
25450578
Stem Cells. 2013 Feb;31(2):259-68
23136034
Nature. 2005 Jun 9;435(7043):834-8
15944708
Nat Cell Biol. 2010 Mar;12(3):286-93
20154680
Tumour Biol. 2014 Aug;35(8):7853-9
24819169
J Biol Chem. 2013 Feb 8;288(6):4035-47
23212913
Nat Rev Cancer. 2006 Apr;6(4):259-69
16557279
Cell. 2004 Jan 23;116(2):281-97
14744438
Mol Cancer Ther. 2015 May;14(5):1162-70
25612617
Cancer Res. 2007 Mar 15;67(6):2456-68
17363563
Cancer Cell. 2010 Jul 13;18(1):52-62
20609352
Tumour Biol. 2014 Feb;35(2):1377-82
24072492
J Pathol. 2012 Apr;226(5):796-805
21960059
Mol Cell Biol. 2008 Oct;28(20):6426-38
18710938
FEBS Lett. 2012 May 21;586(10):1431-8
22673507
Nat Genet. 2007 May;39(5):673-7
17401365